Pharmaceutical Innovations recalls ElectroMist electrode conductivity spray due
Pharmaceutical Innovations recalls ElectroMist electrode conductivity spray solution (product codes 36-3310-25) due to potential failure in antimicrobial effectiveness testing. Affected units include specific lot numbers from 2014-2018.
Lower-risk recall
Potential for failed stability antimicrobial effectiveness testing.
Contact the company
What happened, in plain English
Pharmaceutical Innovations is recalling ElectroMist electrode conductivity spray solution (product code 36-3310-25) because it may not work properly to prevent microbial growth. This could lead to contamination if the product is used in medical settings. Read more at govinfonow.com/recall/67634-pharmaceutical-innovations-recalls-electromist-electrode-conductivity-spray-due-to-antimicrobial.
Source Summary by GovInfoNow · govinfonow.com/recall/67634-pharmaceutical-innovations-recalls-electromist-electrode-conductivity-spray-due-to-antimicrobial · Updated August 20, 2026 · FDA enforcement record: FDA #Z-1969-2019
Cite this page
“Pharmaceutical Innovations recalls ElectroMist electrode conductivity spray due.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/67634-pharmaceutical-innovations-recalls-electromist-electrode-conductivity-spray-due-to-antimicrobial. Based on FDA recall #Z-1969-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1969-2019%22&limit=1).
Why it’s dangerous
The product may fail antimicrobial effectiveness testing, meaning it could not properly prevent microbial growth. This risk is specific to medical use where contamination could occur.
Who’s affected
Users of ElectroMist electrode conductivity spray solution for medical applications are affected. Healthcare professionals and facilities using the product are most at risk.
How to tell if you have this one
Check for product code 36-3310-25 on the ElectroMist electrode conductivity spray solution. Affected lots include 060714-25 through 102018-25, sold between 2014 and 2018.
- Brand
Pharmaceutical Innovations- Category
Medical device
All 5 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
US nationwide distribution including the states of AZ, CA, CT, FL, IL, MA, MI, MN, NC, NJ, NY, OH, PA, RI, TX, TN, VT, WV. Distributed Internationally to accounts in Australia, France, Germany, Hong Kong, Saudi Arabia and Canada.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| Z-1968-2019 | Alpha Conducting solution product codes:3310-15 ACS - Product Usage: Electrode conductivity spray solution.; Lot # 081914-15, 111715-15, 070116-15, 020117-15, 080117-15, 010118-15, 041618-15, 041618A-15, 071618-15, 102018-15 | 87140 |
| Z-1969-2019 | ElectroMist product codes: 36-3310-25 - Product Usage: Electrode conductivity spray solution.; Lot # 060714-25, 080614-25, 101515-25, 070116-25, 072816-25A, 072816-25, 021317-25, 010118-25,102018-25. | 71653 |
| Z-1970-2019 | ElectroMist product codes: 36-3310-60 - Product Usage: Electrode Conductivity Spray Solution.; Lot # 051914-60, 101615-60, 021317-60 | 8982 |
| Z-1971-2019 | ElectroMist product codes: 36-3310-04 - Product Usage: Electrode Conductivity Spray Solution.; Lot # 030215-04, 011716-04, 072816-04, 072816-04, 071618-04, 080117-04 | 630 |
| Z-1972-2019 | Alpha Conducting solution product codes: 3310-25 ASCR - Product Usage: Electrode Conductivity Spray Solution.; Lot # 032014-25, 060515-25,101615-25, 011716-25, 021317-25, 080117-25, 010118A-25, 041618-25, 071618-25, 102018A-25 | N/A |
What to do — step by step
Check Product Code
Look for product code 36-3310-25 on the ElectroMist electrode conductivity spray solution.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 18 states.
FDA distribution: “US nationwide distribution including the states of AZ, CA, CT, FL, IL, MA, MI, MN, NC, NJ, NY, OH, PA, RI, TX, TN, VT, WV. Distributed Internationally to accounts in Australia, France, Germany, Hong Kong, Saudi Arabia and Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Arizona, California, Connecticut, Florida, Illinois, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, Texas, Vermont, West Virginia.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1969-2019 (June 19, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1969-2019 to see it in context.
- Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.